---
category: listing
circular_id: 08b1cd51520711fb
date: '2025-08-29'
description: BSE lists 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance,
  effective September 01, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={ED9CEDD3-5E0D-4F93-B463-BE5E9EB1A3DB}&noticeno=20250829-3&dt=08/29/2025&icount=3&totcount=61&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Administrative listing of small number of bonus shares kept in abeyance
  with minimal market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250829-3&attachedId=
processing:
  attempts: 1
  content_hash: 7460b2aee5583085
  processed_at: '2025-08-29T18:42:02.160141'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-29T06:03:02+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={ED9CEDD3-5E0D-4F93-B463-BE5E9EB1A3DB}&noticeno=20250829-3&dt=08/29/2025&icount=3&totcount=61&flag=0
severity: low
source: bse
stocks:
- IPCALAB
tags:
- bonus-shares
- listing
- equity
- ipca-laboratories
- abeyance
title: Listing of 1000 Bonus Equity Shares kept in abeyance of Ipca Laboratories Ltd
---

## Summary

BSE has announced the listing of 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were kept in abeyance. These shares will be permitted to trade with effect from Monday, September 01, 2025.

## Key Points

- 1000 bonus equity shares of Rs. 1/- each being listed
- Shares were previously kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers: 1171453 to 1172452
- Trading to commence from September 01, 2025

## Regulatory Changes

No regulatory changes introduced. This is an administrative listing of previously issued but held-back bonus shares.

## Compliance Requirements

Trading members are informed about the new securities available for trading from the effective date.

## Important Dates

- **Effective Date**: Monday, September 01, 2025 - Trading commencement date
- **Notice Date**: August 29, 2025

## Impact Assessment

Minimal market impact as this involves a small number of bonus shares (1000 shares) of Ipca Laboratories being released from abeyance status. The shares represent a negligible portion relative to the company's total equity base.